menu search

Hagens berman, national trial attorneys, encourages catalent (ctlt) investors with substantial losses to contact firm’s attorneys, securities fraud class action filed

SAN FRANCISCO, Feb. 27, 2023 (GLOBE NEWSWIRE) — Hagens Berman urges Catalent, Inc. (NYSE: CTLT) investors who suffered substantial losses submit you...

February 28, 2023, 2:09 am

Catalent, inc. (ctlt) q2 2023 earnings call transcript

Catalent, Inc. (NYSE:CTLT ) Q2 2023 Results Conference Call February 7, 2023 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Re...

February 7, 2023, 1:06 pm

Compared to estimates, catalent (ctlt) q2 earnings: a look at key metrics

Although the revenue and EPS for Catalent (CTLT) give a sense of how its business performed in the quarter ended December 2022, it might be worth cons...

February 7, 2023, 12:48 pm

Catalent (ctlt) misses q2 earnings estimates

Catalent (CTLT) delivered earnings and revenue surprises of -6.94% and 2.41%, respectively, for the quarter ended December 2022. Do the numbers hold c...

February 7, 2023, 9:47 am

Ctlt stock: 19.54% surge explanation

The stock price of Catalent Inc (NYSE: CTLT) surged by 19.54% today. This is why....

February 6, 2023, 10:52 pm

Why is catalent (nyse:ctlt) stock up 20% today?

Catalent (NYSE: ctlt ), which manufactures pharmaceutical products, is soaring more than 20% in early t...

February 6, 2023, 10:48 am

Catalent stock rockets 21% premarket on report of takeover interest from danaher

Life Sciences Company Danaher Corp. DHR, -0.31% is interested in taking over contract manufacturer Catalent Inc. CTLT, -1.04% and is willing to pay a ...

February 6, 2023, 6:35 am

Catalent, inc. announces second quarter fiscal year 2023 earnings conference webcast

SOMERSET, N.J.--( BUSINESS WIRE )--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimiz...

January 20, 2023, 8:38 am

Catalent's (ctlt) new deal to utilize its zydis odt technology

Catalent's (CTLT) latest development and license agreement is expected to accelerate the administration of therapeutic doses of active drugs....

January 16, 2023, 12:47 pm

Catalent, inc. to present at the 41st annual j.p. morgan healthcare conference

SOMERSET, N.J.--( BUSINESS WIRE )--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimiz...

January 3, 2023, 5:15 pm

Catalent (ctlt) expands facility capabilities in shanghai

Catalent's (CTLT) latest capability expansion is expected to boost its business in the clinical trials space in its Asia-Pacific Clinical Supply Servi...

December 6, 2022, 9:47 am

Catalent (ctlt) stock down despite q4 beat: will it recover?

Catalent's (CTLT) fiscal fourth-quarter earnings beat but the stock falls 7.4% following the earnings release on Aug 29. Here we discuss the factors t...

August 30, 2022, 12:47 pm

Catalent (ctlt) q4 earnings surpass estimates

Catalent (CTLT) delivered earnings and revenue surprises of 3.48% and 0.89%, respectively, for the quarter ended June 2022. Do the numbers hold clues ...

August 29, 2022, 9:47 am

Asrt vs. ctlt: which stock is the better value option?

ASRT vs. CTLT: Which Stock Is the Better Value Option?...

August 4, 2022, 12:47 pm

A technical look at catalent stock after last week's big update

Catalent Inc (NYSE:CTLT) is a multinational company that enables pharma, biotech, and consumer health partners to optimize product development, launch...

July 12, 2022, 1:39 pm

Catalent (ctlt) expands packaging capabilities at japan facility

Catalent's (CTLT) latest capability expansion is expected to boost its business in this key hub in its Asia-Pacific Clinical Supply Services network....

June 30, 2022, 12:29 pm

3 reasons to retain catalent (ctlt) stock in your portfolio

Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock....

June 29, 2022, 2:42 pm

Reasons to retain catalent (ctlt) stock in your portfolio

Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism on the stock....

May 23, 2022, 12:48 pm

Catalent, inc. (ctlt) ceo john chiminski on q3 2022 results - earnings call transcript

Catalent, Inc. (NYSE:CTLT ) Q3 2022 Earnings Conference Call May 3, 2022 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relati...

May 3, 2022, 1:02 pm

Why erytech pharma are shares moving higher today

Erytech Pharma SA (NASDAQ: ERYP) has sold its US manufacturing facility to Catalent Inc (NYSE: CTLT) for $44.5 million. Catalent will acquire Eryt...

April 25, 2022, 7:15 am


Search within

Pages Search Results: